GGrantIndex
Sort

11,323 grants matching glioblastoma

Mayo SPORE in Brain Cancer

$2,042,068
Brian Patrick O'Neill · Mayo Clinic Rochester · P50 · FY2006 · CA

Brain Tumor Therapeutic Efficacy by Quantitative MR

$2,036,592
Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2015 · CA

Duke SPORE in Brain Cancer

$2,036,564
John H Sampson · Duke University · P50 · FY2016 · CA

GENE THERAPY FOR BRAIN TUMORS

$2,035,660
Massachusetts General Hospital · P01 · FY2001 · CA

Mayo SPORE in Brain Cancer

$2,032,907
Brian Patrick O'Neill · Mayo Clinic Rochester · P50 · FY2014 · CA

Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs

$2,032,638
Peter Karl Sorger · Harvard Medical School · U54 · FY2021 · CA

Molecular Profiling of Clinical Specimens

$2,032,400
Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Molecularly Targeted Radiosensitization of Locally Advanced Cancers

$2,027,150
Theodore S Lawrence · University Of Michigan At Ann Arbor · P50 · FY2025 · CA

GENE THERAPY FOR BRAIN TUMORS

$2,022,442
Massachusetts General Hospital · P01 · FY2000 · CA

Sex-based Differences in Glioma

$2,019,654
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · CA

Systems Analysis of Stress-adapted Cancer Organelles (SASCO) Center

$2,018,318
Kevin A Janes · University Of Virginia · U54 · FY2024 · CA

Sex-based Differences in Glioma

$2,017,250
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · P01 · FY2023 · CA

Brain Tumor Therapeutic Efficacy by Quantitative MR

$2,012,389
Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2013 · CA

MIT/Mayo Physical Sciences Center for Drug Distribution and Efficacy in Brain Tumors

$2,012,210
Forest M White · Massachusetts Institute Of Technology · U54 · FY2017 · CA

Genetics and Biology of Malignant Glioma

$2,011,188
Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2008 · CA

Quantitative systems biology of glioblastoma cells and their interactions with the neuronal and immunological milieu

$2,006,283
Forest M White · Massachusetts Institute Of Technology · U54 · FY2023 · CA

Improving the Clinical Effectiveness and Understanding of the Biophysical Basis

$2,002,699
Theodore S Hong · Massachusetts General Hospital · U19 · FY2018 · CA

Quantitative systems biology of glioblastoma cells and their interactions with the neuronal and immunological milieu

$2,002,011
Forest M White · Massachusetts Institute Of Technology · U54 · FY2025 · CA

System Biology Center in New York

$2,000,001
Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · P50 · FY2013 · GM

BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas

$2,000,000
James D Crapo · Biomimetix Jv, Llc · R44 · FY2020 · CA

EFRI CEE: Opening the Gates of Apoptosis in Cancer

$2,000,000
Stefan H Bossmann · Kansas State University · · FY2020 · ENG

BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas

$2,000,000
James D Crapo · Biomimetix Jv, Llc · R44 · FY2021 · CA

Center of Innovation for Brain Tumor Therapeutics

$1,999,213
Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2023 · CA

TOPIC 382 - INTEGRATED IMAGING AND MOLECULAR ANALYSIS OF GLIOBLASTOMA USING SCOPE SEQ ON THE AIR FLOW

$1,997,803
Steve Gebhart · Cell Microsystems, Inc. · N01 · FY2021 · CA

The USC-JHU Cancer Epigenome Characterization Center

$1,994,650
Peter W Laird · University Of Southern California · U24 · FY2010 · CA